2009 October 7, “A Nation at Odds Over Health Care”, in New York Times:
Until today, in my practice as a vitreoretinal surgeon, I offered patients a choice of Avastin or Lucentis, sometimes remarking that Avastin is the socially responsible way to treat wet age-related macular degeneration.